Exploiting D 2 receptor β‐arrestin2‐biased signalling to suppress tumour growth of pituitary adenomas-Reference-Cited by-同舟云学术

Exploiting D 2 receptor β‐arrestin2‐biased signalling to suppress tumour growth of pituitary adenomas

Published:2021-05-26 Issue:17 Volume:178 Page:3570-3586
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:Br J Pharmacol

Author:

Tan Zhoubin¹^ORCID,Lei Zhuowei²,Yan Zisheng¹,Ji Xuetao³,Chang Xiaoai³,Cai Zhi¹,Lu Liang¹,Qi Yiwei¹,Yin Xiumei⁴,Han Xiao³,Lei Ting¹

Affiliation:

1. Sino‐German Neuro‐Oncology Molecular Laboratory, Department of Neurosurgery, Tongji Hospital, Tongji Medical College Huazhong University of Science and Technology Wuhan China

2. Department of Orthopedics, Tongji Hospital, Tongji Medical College Huazhong University of Science and Technology Wuhan China

3. Key Laboratory of Human Functional Genomics of Jiangsu Province Nanjing Medical University Nanjing China

4. Intensive Care Unit Nanjing Jiangning Hospital of Jiangsu Province Nanjing China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bph.15504

Reference57 articles.

1. The Beta-Arrestin-Biased Dopamine D2 Receptor Ligand, UNC9994, Is a Partial Agonist at G-Protein-Mediated Potassium Channel Activation

2. The Concise Guide to PHARMACOLOGY 2019/20: G protein‐coupled receptors;Alexander S. P. H.;British Journal of Pharmacology,2019

3. Goals and practicalities of immunoblotting and immunohistochemistry: A guide for submission to the British Journal of Pharmacology

4. Discovery of -Arrestin-Biased Dopamine D2 Ligands for Probing Signal Transduction Pathways Essential for Antipsychotic Efficacy

5. Anti-proliferative effects and cell death mediated by two isoforms of dopamine D2 receptors in pituitary tumor cells

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Somatostatin receptors and the associated intracellular machinery: the two sides of the coin;Journal of Endocrinology;2024-01-15

2. A β-Arrestin 2-Biased Dopamine Receptor Type 2 (DRD2) Agonist Is More Efficacious Than Cabergoline in Reducing Cell Proliferation in PRL-Secreting but Not in Non-Functioning Pituitary Tumor Cells;Cancers;2023-06-16

3. A Novel Splice Variant of BCAS1 Inhibits β-Arrestin 2 to Promote the Proliferation and Migration of Glioblastoma Cells, and This Effect Was Blocked by Maackiain;Cancers;2022-08-11

4. Hypogonadism in Male Patients with Pituitary Adenoma and Its Related Mechanism: A Review of Literature;Brain Sciences;2022-06-17